Lataa...
Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome
Deferasirox is an iron chelator agent used in the treatment of diseases with iron overload, such as thalassemia and myelodysplastic syndrome. Although the majority of adverse reactions of deferasirox involve gastrointestinal symptoms and increase in serum creatinine and transaminases, skin rashes, s...
Tallennettuna:
| Julkaisussa: | An Bras Dermatol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Sociedade Brasileira de Dermatologia
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5726679/ https://ncbi.nlm.nih.gov/pubmed/29267448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/abd1806-4841.20176688 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|